Aspirin, a Potential GLUT1 Inhibitor in a Vascular Endothelial Cell Line

Recent epidemiological and preclinical studies have revealed that aspirin possesses antitumor properties; one of the mechanisms results from inhibition of angiogenesis. However, the underlying mechanisms of such action remain to be elucidated, in particular, the effect of aspirin on glucose metaboli...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Yabo, Lou, Xiaohan, Wang, Ruirui, Sun, Chanjun, Liu, Xiaomeng, Liu, Shuochuan, Wang, Zibing, Ni, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2019
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6744609/
https://www.ncbi.nlm.nih.gov/pubmed/31565672
http://dx.doi.org/10.1515/med-2019-0062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6744609/
https://www.ncbi.nlm.nih.gov/pubmed/31565672
http://dx.doi.org/10.1515/med-2019-0062

Ejemplares similares